T cell receptor immunotherapy (TCR-T)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T cell receptor immunotherapy (TCR-T), covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]